Physician profile
Guy Mark Lerner
NPI 1770671547
$9,792.49
in general payments reported to CMS, 2019-2025
21 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Addiction Medicine (Anesthesiology) provider received nationally (typical 2025 total: $133).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $347 · 2021: $336 · 2022: $7,474 · 2023: $397 · 2024: $475 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pear Therapeutics (US), INC. | $6,963.20 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $548.41 | 2021-2024 | Caplyta |
| Uswm, LLC | $423.79 | 2021-2024 | Lucemyra, Zimhi |
| Indivior INC. | $382.84 | 2019-2025 | Sublocade |
| Abbvie INC. | $244.06 | 2021-2025 | |
| Braeburn INC. | $234.07 | 2023-2025 | Brixadi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.11 | 2019-2021 | |
| Mdd US Operations, LLC | $185.92 | 2019 | |
| Abbott Laboratories | $154.32 | 2019-2021 | |
| Nevro Corp. | $92.70 | 2019-2020 | |
| Boston Scientific Corporation | $78.20 | 2019-2021 | |
| Orexo US, INC. | $69.89 | 2019-2022 | |
| Si-Bone, INC. | $59.78 | 2019-2021 | |
| Amgen INC. | $31.22 | 2019 | |
| Redhill Biopharma INC. | $20.12 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $19.09 | 2020 | |
| Alkermes, INC. | $17.22 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.34 | 2019 | |
| Assertio Therapeutics, INC. | $15.32 | 2019 | |
| Zyla Life Sciences, INC. | $12.49 | 2020 | |
| Biodelivery Sciences International, INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Lerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.